Stock 002412 HUNAN HANSEN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Hunan Hansen Pharmaceutical Co., Ltd.

Equities

002412

CNE100000PK2

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
6 CNY -0.33% Intraday chart for Hunan Hansen Pharmaceutical Co., Ltd. -1.96% -11.50%
Apr. 26 Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 26 Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Hansen Pharmaceutical Gets Nod to Amend Information for Isoniazid Tablets
MT
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Hunan Hansen Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 20, 2023
CI
Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Hunan Hansen Pharmaceutical Co., Ltd. Announces Board Appointments
CI
Hansen Pharma's Iohexol Injection Passes Drug Regulator's Evaluation
MT
Hunan Hansen Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Hansen Health Industry Co., Ltd. announced that it expects to receive CNY 40 million in funding from Hunan Hansen Pharmaceutical Co., Ltd.
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Hunan Hansen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Hunan Hansen Pharmaceutical Co., Ltd. Approves Cash Dividend for 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002412 Stock
  4. News Hunan Hansen Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW